Literature DB >> 20965885

Twisting arms to angiotensin receptor blockers/antagonists: the turn of cancer.

Massimo Volpe1, Michel Azizi, A H Jan Danser, Genevieve Nguyen, Luis M Ruilope.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20965885     DOI： 10.1093/eurheartj/ehq382

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  11 in total

1.  Reduction of angiotensin A and alamandine vasoactivity in the rabbit model of atherogenesis: differential effects of alamandine and Ang(1-7).

Authors:  Belthrand Habiyakare; Hiba Alsaadon; Michael L Mathai; Alan Hayes; Anthony Zulli
Journal:  Int J Exp Pathol       Date:  2014-06-20       Impact factor: 1.925

Review 2.  2010 position paper of the Italian Society of Hypertension (SIIA): angiotensin receptor blockers and risk of cancer.

Authors:  Massimo Volpe; Alberto Morganti
Journal:  High Blood Press Cardiovasc Prev       Date:  2011-03-01

3.  Angiotensin and systems thinking: wrapping your mind around the big picture.

Authors:  Gary Robert Smith
Journal:  Ochsner J       Date:  2013

Review 4.  Are the antagonists of the renin-angiotensin system also anticancer agents?

Authors:  Chiara Lonati; Alberto Morganti
Journal:  High Blood Press Cardiovasc Prev       Date:  2014-06-11

Review 5.  Aspirin and the Primary Prevention of Cardiovascular Diseases: An Approach Based on Individualized, Integrated Estimation of Risk.

Authors:  Massimo Volpe; Allegra Battistoni; Giovanna Gallo; Roberta Coluccia; Raffaele De Caterina
Journal:  High Blood Press Cardiovasc Prev       Date:  2017-06-01

Review 6.  Angiotensin Receptor Blockers Versus Angiotensin Converting Enzyme Inhibitors for the Treatment of Arterial Hypertension and the Role of Olmesartan.

Authors:  Stefano Omboni; Massimo Volpe
Journal:  Adv Ther       Date:  2018-12-27       Impact factor: 3.845

7.  Assessment of quality and readability of internet-based health information related to commonly prescribed angiotensin receptor blockers.

Authors:  Anuoluwapo Oloidi; Sabina Onyinye Nduaguba; Kehinde Obamiro
Journal:  Pan Afr Med J       Date:  2020-03-11

Review 8.  Recent Warnings about Antihypertensive Drugs and Cancer Risk: Where Do They Come From?

Authors:  Allegra Battistoni; Massimo Volpe
Journal:  Eur Cardiol       Date:  2020-04-30

9.  Effect of angiotensin receptor blockers on the development of cancer: A nationwide cohort study in korea.

Authors:  Mi-Hyang Jung; Ju-Hee Lee; Chan Joo Lee; Jeong-Hun Shin; Si Hyuck Kang; Chang Hee Kwon; Dae-Hee Kim; Woo-Hyeun Kim; Hack Lyoung Kim; Hyue Mee Kim; In Jeong Cho; Iksung Cho; Jinseub Hwang; Soorack Ryu; Chaeyeong Kang; Hae-Young Lee; Wook-Jin Chung; Sang-Hyun Ihm; Kwang Il Kim; Eun Joo Cho; Il-Suk Sohn; Sungha Park; Jinho Shin; Sung Kee Ryu; Moo-Yong Rhee; Seok-Min Kang; Wook Bum Pyun; Myeong-Chan Cho; Ki-Chul Sung
Journal:  J Clin Hypertens (Greenwich)       Date:  2021-01-25       Impact factor: 3.738

10.  The renin-angiotensin system blockers and survival in digestive system malignancies: A systematic review and meta-analysis.

Authors:  Qi Zhou; Di-Shi Chen; Lin Xin; Li-Qiang Zhou; Hou-Ting Zhang; Li Liu; Yi-Wu Yuan; Shi-Hao Li
Journal:  Medicine (Baltimore)       Date:  2020-02       Impact factor: 1.817
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.